Toth Financial Advisory’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-250
Closed -$875 – 1106
2026
Q2
$875 Hold
250
– – ﹤0.01% 846
2026
Q1
$965 Buy
+250
New +$984 ﹤0.01% 817

Other funds holding VYGR

Toth Financial Advisory's VYGR Position: Q3 2026 in Review

Toth Financial Advisory sold out of Voyager Therapeutics (VYGR) in Q3 2026, closing a stake of 250 shares — an estimated $875 sold.

Toth Financial Advisory first reported a position in VYGR in Q1 2026 and held it in 2 quarters. The position peaked at $965 in Q1 2026. 2 funds tracked by Wall St. Rank hold VYGR as of Q3 2026.

  • Toth Financial Advisory reported no remaining Voyager Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Toth Financial Advisory sold 250 Voyager Therapeutics shares in Q3 2026, an estimated $875.
  • Toth Financial Advisory first reported a position in Voyager Therapeutics in Q1 2026 and held it in 2 quarters.
  • Toth Financial Advisory's Voyager Therapeutics position peaked at $965 in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.